New Jersey S 2387: Requires pharmaceutical manufacturers and wholesale distributors to report certain manufacturing and dispensing information concerning prescription opioid drugs, medication-assisted treatment drugs, and opioid antidote drugs.*

Status: Referred to Senate Budget and Appropriations Committee (as of 2019-06-17)

State: New Jersey · Session: 218 · Bill: S 2387

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Singleton, Troy

View New Jersey S 2387 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.